Crossmark

Earth-friendly-assessed silver-nanoparticles spectrophotometric method for rapid and sensitive analysis of Molnupiravir, an FDA-approved candidate for COVID-19: application on pharmaceutical formulation and dissolution test

Crossref DOI link: https://doi.org/10.1186/s13065-023-00933-2

Published Online: 2023-03-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mohamed, Ahmed R.

Abolmagd, Ebrahim

Nour, Israa M.

Badrawy, Mohamed

Hasan, Mohamed A.
Funding

Funding for this research was provided by:

Egyptian Russian University
License Information

Text and Data Mining valid from 2023-03-10

Version of Record valid from 2023-03-10
More Information

Article History

Received: 22 April 2022

Accepted: 28 February 2023

First Online: 10 March 2023

Declarations

:

: Not applicable.

: Not applicable.

: We have no competing of interest to disclose.

Document is current

Any future updates will be listed below